The pathophysiology of agitation

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Agitation is a nonspecific behavioral syndrome observed in diverse clinical conditions.
• Its presentation is typically characterized by a fluctuating course.
• Agitation is associated with dysregulation in multiple neurotransmitter systems, including dopaminergic, serotonergic, noradrenergic, and GABAergic pathways.

Purpose of the Study:

• To discuss the pathophysiologic mechanisms underlying agitation across different clinical disorders.
• To explore the lack of distinct clinical features associated with specific pathophysiologic abnormalities.
• To propose a clinical approach focusing on the underlying psychiatric disorder and its pathophysiology.

Main Methods:

• Review and discussion of existing literature on the pathophysiology of agitation.
• Analysis of neurotransmitter system dysregulations implicated in agitation.
• Synthesis of clinical observations and theoretical frameworks related to agitation.

Main Results:

• Agitation arises from complex, multifactorial pathophysiologic abnormalities.
• No single unifying etiologic pathophysiology explains all cases of agitation.
• Neurotransmitter dysregulations (dopaminergic, serotonergic, noradrenergic, GABAergic) are key mediators.

Conclusions:

• Treatment interventions should target the overarching psychiatric disorder and its specific pathophysiology.
• Pharmacological agents that modulate neurotransmitter systems (e.g., reducing dopaminergic/noradrenergic tone, increasing serotonergic/GABAergic tone) can effectively manage agitation.
• Management strategies may be effective irrespective of the specific underlying etiology.